Lv0
0 积分 2023-08-04 加入
First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer
1小时前
待确认
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
2小时前
已完结
Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer
1天前
已完结
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
3天前
已完结
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Treatment advances across the cervical cancer spectrum
1个月前
已完结
Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer
1个月前
已完结
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Immune-checkpoint blockade in surgical management of gastric or gastro-oesophageal junction adenocarcinoma
1个月前
已完结
Oncological and functional outcomes of salvage surgery for local oropharyngeal cancer recurrence after primary Radiation±Chemotherapy
2个月前
已关闭
皖公网安备34019202002308
